User:Eran Hodis/Sandbox: Difference between revisions

From Proteopedia
Jump to navigationJump to search
Eran Hodis (talk | contribs)
No edit summary
Eran Hodis (talk | contribs)
No edit summary
 
(26 intermediate revisions by the same user not shown)
Line 1: Line 1:
<imagemap>
Influenza neuraminidase
Image:Foo.jpg|200px|picture of a foo
 
poly 131 45 213 41 210 110 127 109 [[Display]]
Influenza '''neuraminidase''' is a glycoprotein in the influenza virus membrane. Before an infected cell can release the virus into its surroundings to infect new cells, neuraminidase must cleave sialic acid from both virus and cellular glycoproteins.
poly 104 126 105 171 269 162 267 124 [[Keyboard]]
 
rect 15 95 94 176  [[Foo type A]]
Because of its important role in virus infectivity, several anti-viral drugs have been designed to target neuraminidase, including oseltamivir (Tamiflu) and zanamivir (Relenza). Tamiflu binding to neuraminidase moves glutamate 276 towards histidine 274, making more room for Tamiflu to bind tightly (PDB entry [[2hu4]]). But, in a common mutant (H274Y), a larger tyrosine replaces the smaller histidine 274, preventing glutamate 276 from moving to make room for Tamiflu binding, resulting in weaker drug binding and thus resistance (PDB entry 3cl0). Luckily the H274Y neuraminidase mutant is still susceptible to Relenza, which is smaller than Tamiflu.
# A comment, this line is ignored
 
circle 57 57 20    [[Foo type B]]
<quiz display=simple>
desc bottom-left
{Which neuraminidase residue moves to make room for Tamiflu binding but cannot do so in the H274Y neuraminidase mutant?}
</imagemap>
- histidine 274
- serine 278
+ glutamate 276
- tyrosine 274
</quiz>